Blanket Purchase Agreement 36F79719D0244-36C24121A0063

Award Date 8/1/21
Last Date to Order 7/31/22
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
Coronavirus COVID-19
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The key products and services being delivered under this federal contract IDV award are in vitro diagnostic reagents, test kits, and related medical laboratory equipment and services. The prime contractor, Luminex Corporation, was awarded a Federal Supply Schedule (FSS) contract by the Department of Veterans Affairs (VA) to provide these specialized biological testing technologies and support services. Luminex's proprietary platforms, assays, and diagnostic solutions enable automated analysis of...
The federal contract IDV award is a Blanket Purchase Agreement (BPA) awarded by the Department of the Air Force's 711th Human Performance Wing/USAF School of Aerospace Medicine (USAFSAM) to Luminex Corporation, a foreign-owned manufacturer of advanced multiplex diagnostic solutions. The single-award BPA, with a ceiling value of $5,762,500.00, is for the procurement of LUMINEX REAGENTS to support the agency's medical testing, research, and diagnostic needs. The BPA is primarily issued under the...
The Department of Veterans Affairs (VA) awarded a single-award Blanket Purchase Agreement (BPA) to Luminex Corporation, a foreign-owned, for-profit manufacturer of biological testing technologies, to provide polymerase chain reaction (PCR) testing services to the VA Pittsburgh Healthcare System. The contract, valued at $519,140.00, has a period of performance through June 30, 2026 and was awarded on July 1, 2023. The BPA includes two task orders, with the first order valued at $532,050.05 and...
Luminex Corporation was awarded a blanket purchase agreement by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 to deliver COVID-19 diagnostic test kits. The BPA establishes a single award vehicle with a potential value of $360,000 to acquire NXTAG EXTENDED PANELS and NXTAG COVID EXTENDED PANELS. Two firm fixed price task orders were issued against the BPA for a total of $720,000 to support the agency's coronavirus response efforts. The...
Luminex Corporation was awarded a blanket purchase agreement as a prime contractor to provide reagents, consumables, and diagnostic testing services to the Department of Veterans Affairs Veterans Health Administration. Under the first task order valued at $100,000, Luminex will deliver Luminex reagents to Veterans Integrated Service Network 1 in Austin, Texas from August 1, 2023 through July 31, 2024. A subsequent task order for $54,542.40 calls for reagents, consumables, and Luminex...
This federal contract Indefinite Delivery Vehicle (IDV) is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The BPA, valued up to $3.2 million, is for the provision of Alinity M reagents and supplies, including COVID-19 testing reagents, to support the VA's medical diagnostic operations. The contract does not utilize any set-aside designations, as Abbott Molecular is a large business. The BPA...
The Department of Veterans Affairs Veterans Health Administration awarded a blanket purchase agreement to Luminex Corporation under the Multiple Award Schedule contracting vehicle. The BPA includes two firm fixed price call orders totaling $170,918.68 to procure COVID-19 testing analyzers, supplies, and equipment. The first call order valued at $37,929.99 is for a COVID-19 analyzer to support VISN 4 pandemic response efforts through March 2022 in Pittsburgh, Pennsylvania. The second call order...
This federal contract Indefinite Delivery Vehicle (IDV) is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) to Biofire Diagnostics LLC, a foreign-owned, for-profit biotechnology company. The BPA, valued at up to $7,000,000, is issued under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. It allows for streamlined, as-needed procurement of Biofire's advanced...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Becton, Dickinson & Co (BD), a manufacturer of medical devices, instruments, and in-vitro diagnostics. The $3 million contract has a period of performance through July 2027 and provides for the delivery of COVID-19 diagnostic testing reagents to support VA healthcare facilities. Several delivery orders have been issued against this IDC, valued at $542,889.96, $542,889.96, $11,015.58, and...
The federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc. The contract has a ceiling value of $4,676,479.65 and a period of performance through December 31, 2027. The BPA is established under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, and is focused on procuring Abbott BinaxNOW COVID-19 antigen test cards to support the VA's...

The federal contract IDV award is a Blanket Purchase Agreement (BPA) issued by the Department of Veterans Affairs (VA) to Luminex Corp, a manufacturer of biological testing technologies including multiplex diagnostic solutions. The BPA has a total ceiling value of $757,790.64 and a period of performance through July 31, 2022.

Under this single award BPA, Luminex Corp has received two specific call orders to date. The first, valued at $164,760.47, is for the provision of Luminex reagents to support COVID-19 testing efforts within the VA's Veterans Integrated Service Network 1 region, with a period of performance through January 31, 2022. The second call order, valued at $26,937.00, is for reagents and consumables for COVID-19 testing, with a period of performance through July 31, 2022. Both call orders were issued under the GSA Schedule program for In Vitro Diagnostics, Reagents, and Test Kits, and were not set aside for any specific business category.

Generated 10/26/24, 9:13 AM